ROBIN RISKY: Open Payments
NPI 1073267266 · EDWARDSVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$433 in 21 payments from 8 companies in 2025. Trend: 2023 $303 · 2024 $532 · 2025 $433
Food & beverage: $433
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $124 |
| ABBVIE INC. | 4 | $89 |
| Axsome Therapeutics, Inc. | 4 | $70 |
| Novartis Pharmaceuticals Corporation | 2 | $61 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Exact Sciences Corporation | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
Products named: Auvelity, Wegovy, LEQVIO, Ozempic, QULIPTA, UBRELVY, VRAYLAR, FARXIGA.
Industry payments across IL — which companies pay providers there.
